Skip to main content
Log in

Meandering Down the Road to Transparency

  • Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rovira J. Transparency of economic evaluations of health technologies. Pharmacoeconomics 2008; 26 (3): 181–3

    Article  PubMed  Google Scholar 

  2. Hill S. Transparency in economic evaluations. Pharmacoeconomics 2005; 23 (10): 967–9

    Article  PubMed  Google Scholar 

  3. Bell CM, Urbach DR, Ray JG, et al. Bias in published cost effectiveness studies: systematic review. BMJ 2006; 332 (7543): 699–703

    Article  PubMed  Google Scholar 

  4. Drummond MF. A reappraisal of economic evaluation of pharmaceuticals. Pharmacoeconomics 1998; 14 (1): 1–9

    Article  PubMed  CAS  Google Scholar 

  5. Hill SR, Mitchell AS, Henry DA. Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme. JAMA 2000; 283 (16): 2116–21

    Article  PubMed  CAS  Google Scholar 

  6. Wager E, Middleton P. Technical editing of research reports in biomedical journals. Cochrane Database Syst Rev 2007 Apr 18; (2): MR000002

    PubMed  Google Scholar 

  7. Carswell CI, McWilliams P. It’s a matter of perspective [poster]. In press

  8. Carswell CI, Paladino JA. Reporting pharmacoeconomic evaluations. Pharmacoeconomics 2005; 23 (11): 1073

    Article  PubMed  CAS  Google Scholar 

  9. Haycox A. When NICE says no! Pharmacoeconomics 2007; 25 (12): 995–6

    Article  PubMed  Google Scholar 

  10. Getsios D, Migliaccio-Walle K, Caro JJ. NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? Pharmacoeconomics 2007; 25 (12): 997–1006

    Article  PubMed  Google Scholar 

  11. Godlee F. Making reviewers visible: openness, accountability, and credit. JAMA 2002; 287 (21): 2762–5

    Article  PubMed  Google Scholar 

  12. BMJ Publishing Group, Ltd. Peer review process [online]. Available from URL: http://resources.bmj.com/bmj/authors/article-submission/peer-review-process/peer-review-process?grp=l [Accessed 2008 Jan 21]

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carswell, C.I., Paladino, J.A. Meandering Down the Road to Transparency. Pharmacoeconomics 26, 179–180 (2008). https://doi.org/10.2165/00019053-200826030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200826030-00001

Navigation